Search
for
Sort by
Research 211–240 of 429
- A bibliometric study of the top 100 most cited articles on melanoma: insights into research trends and characteristics
- Manifestaciones dermatológicas en pacientes oncológicos pediátricos en un hospital de tercer nivel de Honduras
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Farmácia Avenida - Guimarães e nos Serviços Farmacêuticos da Unidade Local de Saúde do Alto Ave, EPE - Guimarães
- Anais do II Congresso Nacional Acadêmico de Dermatologia
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- ES01.01 Chemotherapy is Strictly Additive to Immunotherapy
- Association of prior 5-α-reductase inhibitor exposure with ICI benefit in metastatic RCC: Multicentre cohort with single-cell immune profiling.
- Resolution of advanced conjunctival squamous cell carcinoma with cemiplimab immunotherapy, IFNα-2b, and retinoic acid treatment over 2 years of follow-up
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Hair aging as an urgent problem of modern medicine
- Extracellular vesicles as human therapeutics: A scoping review of the literature
- Patient-reported outcomes following various incision techniques in breast reconstruction: an observational cohort study in China
- 0441 Systemic autoimmune comorbidity in alopecia totalis and universalis compared with patchy alopecia areata: A retrospective cohort study
- Correction to “the Role of Hsa‐miR‐193a‐5p as an Important Factor for Control of Inositol in Alopecia Areata”
- UTMD Enhances Targeting of Diclofenac and Doxil® to Boost Tumor Immunotherapy
- PD-1+CXCR5−CD4+T cells are correlated with the severity of systemic lupus erythematosus
- Predominance of CD27-PD-1- Effector Memory T Cells Re-Expressing CD45RA Characterizes Treatment-Resistant Severe Alopecia Areata
- 576 INTASYL PH-762: Intratumoral immunotherapy targeting PD-1
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- 1455 Cutaneous wounds healed at the cost of overall fitness in the aged Balb/C mouse model
- Sintilimab-induced Alopecia Universalis in a Patient With the Anti-tumor Effect of Complete Remission After Hepatectomy
- Cutaneous lupus erythematosus induced by tislelizumab
- Recurrent inverse necrotizing infundibular crystalline folliculitis
- A Single-Arm, Open-Label, Phase Ib Clinical Study Evaluating the Efficacy and Safety of Durvalumab in Combination with Albumin-Bound Paclitaxel and Carboplatin as Neoadjuvant Therapy for Resectable Stage III Non-Small Cell Lung Cancer
- 575 INTASYL self-delivering RNAi: A flexible platform to treat dermatological malignancies
- Cutaneous toxicities of new treatments for melanoma
- Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s Disease
- Cemiplimab-Induced Alopecia Areata
- Progress in Dermatology and Venereology in 2023 as reflected in the Journal of the European Academy of Dermatology and Venereology